ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,782Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 5176

$1.02M Total Retail Price of All Prescriptions

Rank: 251 out of 5176

601 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 601 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 601 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 20,251 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
JANTOVEN 1,109 967 1 106
SIMVASTATIN 1,080 1,017 2 1
WARFARIN SODIUM 1,066 1,039 3 13
METOPROLOL TARTRATE 947 880 4 6
OMEPRAZOLE 942 874 5 3
LEVOTHYROXINE SODIUM 606 566 6 4
AMLODIPINE BESYLATE 474 451 7 2
FUROSEMIDE 399 384 8 8
DONEPEZIL HCL 379 379 9 28
LISINOPRIL 372 372 10 5
METFORMIN HCL 349 301 11 7
MIRTAZAPINE 327 322 12 45
HYDROCHLOROTHIAZIDE 277 254 13 10
CITALOPRAM HBR 271 261 14 31
TAMSULOSIN HCL 271 260 14 20
NAMENDA 265 265 16 47
METOPROLOL SUCCINATE 254 236 17 11
QUETIAPINE FUMARATE 223 214 18 75
GABAPENTIN 217 201 19 21
MELOXICAM 211 189 20 53
LEVETIRACETAM 211 175 20 92
JANUVIA 195 190 22 25
CLOPIDOGREL 195 195 22 26
LACTULOSE 192 176 24 87
LEVOFLOXACIN 191 178 25 109
DIGOXIN 183 183 26 56
ZOLPIDEM TARTRATE 180 171 27 17
METOCLOPRAMIDE HCL 177 157 28 176
TRAMADOL HCL-ACETAMINOPHEN 172 165 29 116
ATENOLOL 168 168 30 12
NEXIUM 167 153 31 16
GLIPIZIDE 165 141 32 63
CARVEDILOL 159 148 33 24
PLAVIX 157 156 34 29
LANTUS 141 140 35 66
DIOVAN 141 141 35 19
ALENDRONATE SODIUM 138 138 37 18
IPRATROPIUM-ALBUTEROL 136 128 38 138
GEMFIBROZIL 136 121 38 139
DIOVAN HCT 131 125 40 39
ENALAPRIL MALEATE 131 114 40 22
CLOTRIMAZOLE-BETAMETHASONE 130 124 42 94
SEROQUEL 129 129 43 166
ISOSORBIDE MONONITRATE ER 126 126 44 44
LOSARTAN POTASSIUM 125 89 45 14
FINASTERIDE 115 104 46 69
ATORVASTATIN CALCIUM 114 106 47 9
POTASSIUM CHLORIDE 114 112 47 34
NYSTATIN-TRIAMCINOLONE 114 113 47 142
CARBIDOPA-LEVODOPA 113 111 50 98
GLIMEPIRIDE 112 92 51 37
SERTRALINE HCL 110 96 52 30
FELODIPINE ER 109 109 53 128
CLONIDINE HCL 106 95 54 79
ESCITALOPRAM OXALATE 102 102 55 89
RISPERIDONE 101 101 56 78
ADVAIR DISKUS 100 86 57 32
PREDNISONE 100 83 57 52
FAMOTIDINE 96 94 59 58
HALOPERIDOL 95 94 60 145
LOSARTAN-HYDROCHLOROTHIAZIDE 95 86 60 35
FLUTICASONE PROPIONATE 93 55 62 38
HYDRALAZINE HCL 91 90 63 73
TRAZODONE HCL 91 90 63 71
DILTIAZEM HCL 89 77 65 316
PANTOPRAZOLE SODIUM 83 83 66 61
HYDROCODONE-ACETAMINOPHEN 82 73 S3 67 27
IPRATROPIUM BROMIDE 80 79 68 135
AMOX TR-POTASSIUM CLAVULANATE 79 75 69 141
SANTYL 78 78 70 124
PROAIR HFA 74 68 71 60
SODIUM CHLORIDE 71 69 72 391
ALLOPURINOL 70 70 73 41
CRESTOR 69 51 74 15
SPIRONOLACTONE 64 57 75 88
OLANZAPINE 62 51 76 140
NOVOLOG 59 59 77 168
ALBUTEROL SULFATE 59 58 77 99
NISOLDIPINE 58 46 79 368
COMBIVENT 57 43 80 156
HYDROXYZINE HCL 57 57 R 80 213
AZITHROMYCIN 56 47 82 42
FLOVENT HFA 56 56 82 203
DIVALPROEX SODIUM 53 38 84 104
METFORMIN HCL ER 52 52 85 57
LANSOPRAZOLE 52 52 85 113
SINGULAIR 51 49 87 62
TIMOLOL MALEATE 50 50 88 318
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.